Koyfin Home > Directory > Health Care > Amneal Pharmaceuticals Inc > Long-Term Investments

Amneal Pharmaceuticals Inc Long-Term Investments Chart (AMRX)

Amneal Pharmaceuticals Inc annual/quarterly Long-Term Investments from 2019 to 2019.
Other Cash Flow Metrics:
  • Amneal Pharmaceuticals Inc Cash Flow from Operations for the quarter ending December 12, 2018 was $260m a 89.59% increase of 233m year over year
  • Amneal Pharmaceuticals Inc Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $215m a 94.17% increase of 202m year over year
  • Amneal Pharmaceuticals Inc Total Revenue for the quarter ending December 12, 2018 was $498m a 44.69% increase of 222m year over year
View Chart On Koyfin